Cardiology Advisor Contributing Writer

Researchers sought to examine whether patients with COVID-19 receiving steroids develop new-onset atrial fibrillation.

Researchers analyzed the risk between statin use and risk of mortality among patients hospitalized with COVID-19 in a study presented at AHA 2021.